Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02027857
Other study ID # 20131211-8
Secondary ID
Status Not yet recruiting
Phase N/A
First received December 23, 2013
Last updated January 2, 2014
Start date January 2014
Est. completion date June 2015

Study information

Verified date January 2014
Source Xijing Hospital
Contact Hu Shijie, M.D;Ph.D.
Phone 086-29-84773307
Email hushijie@fmmu.edu.cn
Is FDA regulated No
Health authority China: Ministry of Health
Study type Interventional

Clinical Trial Summary

Brain edema is the main reason for the disability and lethality in traumatic brain injury, which is the most difficult part of emergency rescue. Recently, there is no medical equipment to monitor the early brain edema in clinic. We have found that Electrical impedance tomography (EIT) can perform the real-time and bedside monitoring of brain electrical impedance after single-dose mannitol treatment, which may be a new strategy for the surveillance of brain edema. In this study, we would like to compare the application in traumatic brain edema between EIT and Noninvasive intracranial pressure (ICP) monitoring, including the progress of brain edema, the relationship between impedance and ICP, and the improvement for the patients' prognosis. EIT would probably be a new image strategy for the treatment of traumatic brain injury.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date June 2015
Est. primary completion date January 2015
Accepts healthy volunteers No
Gender Both
Age group 16 Years to 65 Years
Eligibility Inclusion Criteria:

1. Eligible patients were 16 to 65 years of age with all genders.

2. The patients had been diagnosed as traumatic brain injury during 24 hours before enrollment, with the confirmation of CT or MRI.

3. All the patients had provided written informed consent.

6. The patients were receiving usual inpatient rehabilitation and conservative treatment .

Exclusion Criteria:

1. The patients with indication of operation during the research should be excluded.

2. The patients were assessed as unqualified for the study according to the comprehensive evaluation opinion brought forward by the research team.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
EIT monitoring

non-invasive ICP monitoring


Locations

Country Name City State
China Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University Xi'an City Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
Xijing Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary brain electrical impedance After the patients' enrollment, the electrodes would be placed properly and the continuous monitoring of brain impedance just be started. From the 1st day (enrollment) to the 7th day Yes
Secondary Glasgow coma scale(GCS) The scale is composed of three tests: eye, verbal and motor responses. The three values separately as well as their sum are considered. The lowest possible GCS (the sum) is 3 (deep coma or death), while the highest is 15 (fully awake person). on the 0 day of the study Yes
Secondary demographic characteristics at baseline The demographic data include age, gender, injuries reason, time from injuries, and so on. on the 0 day of the study Yes
Secondary kidney function examination There are three main indicators: blood creatinine, urea nitrogen, and uric acid. These indicator are used as a monitor of the kidney safety. On the 1st day, 3rd day, 5th and 7th day Yes
Secondary Physiological and pathological reflex check on the 1st and 7th day Yes
Secondary muscular strength and tension test There are 6 grades in muscular strength test. And muscular tension test was referred to Modified Ashworth scale. on the 1st and 7th day Yes
Secondary non-invasive intracranial pressure This equipment can continuously monitor the change of intracranial pressure since the patients' enrollment. From the 1st day (enrollment) to the 7th day Yes
Secondary brain CT scan Brain CT scan is applied to monitor the degree and progress of the brain change after the medication of mannitol. On the 1st day (enrollment), and 7th day Yes
Secondary Disability Rating Scale (DRS) The DRS includes measures of eye opening, verbalization, and motor response (derived from the Glasgow Coma Scale); cognitive understanding of feeding, dressing, and grooming; degree of assistance and supervision required; and employability. Scores range from 0 to 29, with higher values indicating greater disability. on the 1st day (enrollment), seventh day after hospitalization Yes
Secondary glasgow outcome scale(GOS) GOS includes 5 grades: Dead, Vegetative state, Severe disability, Moderate disability, Good recovery. the patients were discharged or the 7th day after hospitalization Yes